|
1. Accepted major perpetrators |
2. Rejected perpetrators |
3. Unclassifiable |
4. Full table |
levomepromazine is not available in Australia/New Zealand, despite evidence suggesting that it may perturb the activities of CYP2D6.
levomepromazine
| CYP2D6 | |
|---|---|
| Not available in Australia or New Zealand | clemastine deramciclan halofantrine hydroxyzine levomepromazine melperone mepyramine mibefradil midodrine perphenazine propafenone quinidine ranolazine rofecoxib stiripentol thioridazine tripelennamine |
Footnotes and References
Disclaimer
WARNING: While all efforts were put in to maintain the accuracy and currency of the information, it is possible that the knowledge and electronic tools may contain errors and inadequacy.
Both Flinder's University and University of New South Wales are not liable to any damages or losses resulted from such circumstances. Clinical discretions are strongly advised at all times.